Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Payables (2020 - 2025)

IceCure Medical (ICCM) has disclosed Payables for 6 consecutive years, with $863000.0 as the latest value for Q4 2025.

  • Quarterly Payables fell 29.95% to $863000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $863000.0 through Dec 2025, down 29.95% year-over-year, with the annual reading at $863000.0 for FY2025, 29.95% down from the prior year.
  • Payables for Q4 2025 was $863000.0 at IceCure Medical, down from $1.2 million in the prior quarter.
  • The five-year high for Payables was $1.2 million in Q4 2024, with the low at $502000.0 in Q4 2023.
  • Average Payables over 5 years is $838400.0, with a median of $863000.0 recorded in 2025.
  • The sharpest move saw Payables surged 145.42% in 2024, then fell 29.95% in 2025.
  • Over 5 years, Payables stood at $881000.0 in 2021, then dropped by 18.96% to $714000.0 in 2022, then decreased by 29.69% to $502000.0 in 2023, then soared by 145.42% to $1.2 million in 2024, then dropped by 29.95% to $863000.0 in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $863000.0, $1.2 million, and $502000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.